Eli Lilly and Company
ANTI-RANKL ANTIBODIES AND USES THEREOF

Abstract:

Antibodies and methods of using these antibodies are provided which bind human and mouse receptor activator of nuclear factor kappa-B ligand, said antibodies are useful as agents for treating conditions associated with bone-related disorders or skeletal abnormalities caused by cancer.